A novel nuclear inhibitor I-92 regulates DNA binding activity of octamer binding protein p92 during the cell cycle

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Jürgen Weitz - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Marijana Kopun - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • M. Stoehr - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Inge Napierski - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)
  • Hans dieter Royer - , Deutsches Krebsforschungszentrum (DKFZ) (Autor:in)

Abstract

Nuclear DNA binding protein p92 is a sequence specific octamer binding protein with identical molecular weight as the ubiquitous octamer binding protein Oct-1. It binds to octamer related sequences from the enhancer of human papillomavirus type 18. The activity and intracellular distribution of p92 is regulated by extracellular signals. In serum starved Hela-fibroblast hybrid cells p92 is localized to the cytosol. Serum stimulation leads to nuclear import of p92. In fractions of asynchronously growing cells, which were separated according to cell cycle phases into G1, S, and G2 populations by centrifugal elutriation, p92 DNA binding is confined to S phase. In binding site blots however, p92 DNA binding activity is also present in G1 and G2. In G1 and G2 DNA binding activity of p92 is masked by a novel nuclear inhibitor I-92. The cyclic association of p92 with its inhibitor I-92 provides a new mechanism of regulating S phase dependent activity of a sequence specific DNA binding protein.

Details

OriginalspracheEnglisch
Seiten (von - bis)5725-5730
Seitenumfang6
FachzeitschriftNucleic acids research
Jahrgang19
Ausgabenummer20
PublikationsstatusVeröffentlicht - 25 Okt. 1991
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

PubMed 1945850

Schlagworte

ASJC Scopus Sachgebiete